Female Pelvic Med Reconstr Surg 2021 Oct 19. Epub 2021 Oct 19.
From the Urogynecology and Pelvic Reconstructive Surgery, MultiCare Health Systems, Tacoma, WA Division of Urognecology, The Oregon Clinic, Portland, OR Female Pelvic Medicine and Reconstructive Surgery, University of California, Irvine, Orange, CA Department of Obstetrics and Gynecology and Department of Urology, Mayo Clinic, Rochester, MN Urogynecology and Reconstructive Pelvic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC Department of Obstetrics and Gynecology, Female Pelvic Medicine and Reconstructive Surgery, Oregon Health & Science University, Portland, OR Department of Obstetrics and Gynecology, Female Pelvic Medicine and Reconstructive Surgery, Penn State College of Medicine, Hershey, PA.
Objective: This study aimed to provide female pelvic medicine and reconstructive surgery (FPMRS) providers with evidence-based guidance on opioid prescribing following surgery.
Methods: A literature search of English language publications between January 1, 2000, and March 31, 2021, was conducted. Search terms identified reports on opioid prescribing, perioperative opioid use, and postoperative pain after FPMRS procedures. Read More